Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
dc.identifier.doi
10.2217/fon-2022-1287
dc.identifier.other
WOS:000991646700001
dc.description.volume
dc.description.issue
Publisher
FUTURE MEDICINE LTD
DOI
10.2217/fon-2022-1287